GLP-1 Drugs Associated with Higher Remission in Ulcerative Colitis

A retrospective study of 300 patients with ulcerative colitis found that those using liraglutide or semaglutide had significantly higher remission rates at 4, 8, and 12 weeks compared with non-users. The association remained strong after adjusting for factors like obesity and diabetes, and was independent of weight loss. The authors suggest these drugs may have an anti-inflammatory effect that could complement existing treatments.